Chart review of patients with COPD, using medical records and artificial intelligence

SEPAR (Spanish Society Pneumology and Thoracic Surgery)0 个研究点目标入组 2,500,000 人开始时间: 2020年1月24日最近更新: 2020年2月10日

适应症

试验速览

暂无简介。

•1. Subjects aged = 35 years old, smokers or former smokers of more than 10 pack-years
•2. Had a diagnosis of COPD (a post-bronchodilator ratio forced expiratory volume in the first second [FEV1] / forced vital capacity [FVC] < 0.70, and the presence of respiratory symptoms such as cough, sputum, and dyspnoea)
•3. Admitted for ‘‘respiratory disease’’ [respiratory infection or pleural effusion (OR) respiratory failure (OR) right/left heart failure (OR) chronic bronchitis (OR) bronchospasms (AND) [historical diagnosis of COPD (OR) a documented FEV1/FVC < 0.70 in the absence of other obstructive diseases, such as asthma or bronchiolitis]

•Patients with a specific diagnosis upon admission of pulmonary oedema, pneumonia, radiological infiltration, pulmonary embolism, pneumothorax, rib fractures, aspiration, or any other associated respiratory or of non-respiratory condition, such as major cardiopathy with chronic heart failure, extended neoplasia, liver or kidney failure.

发起方

SEPAR (Spanish Society Pneumology and Thoracic Surgery)